Looking for Pharmaceutical Excipients offered by Ulanqab Kema New Material? Find MolPort-001-792-519 to address your drug delivery challenges on PharmaCompass.

MolPort-001-792-519

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 7 USDMF, 1 CEP/COS, 4 EU WC, 6 NDC API, 11 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

40 FDF Dossiers, 19 FDA Orange Book, 16 Europe, 1 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 250MG, TABLET;ORAL - 500MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 1 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 7 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 24 Kerry, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 4 Pluviaendo, 4 Prachin Chemical, 14 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 36 Disintegrants & Superdisintegrants, 35 Direct Compression, 23 Granulation, 17 Thickeners and Stabilizers, 15 Lubricants & Glidants, 14 Co-Processed Excipients, 10 Solubilizers, 7 Coating Systems & Additives, 7 Film Formers & Plasticizers, 7 Controlled & Modified Release, 5 Chewable & Orodispersible Aids, 4 Parenteral, 4 Emulsifying Agents, 2 Taste Masking, 2 Topical, 2 Rheology Modifiers, 1 API Stability Enhancers